Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations

BACKGROUND: The amplification of epidermal growth factor receptor (EGFR) in triple negative breast carcinomas (TNBC) suggests its potential therapeutic application, as for HER-2, using standardised methods of measurement. In this regard, we aimed to compare several methods for evaluating EGFR amplif...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Secq, V, Villeret, J, Fina, F, Carmassi, M, Carcopino, X, Garcia, S, Metellus, I, Boubli, L, Iovanna, J, Charpin, C
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2014
Предметы:
Molecular Diagnostics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3929875/
https://ncbi.nlm.nih.gov/pubmed/24423920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.794
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы